Finance logo
right-img
Home
Featured News
Finance News
Banking News
Home
| Congress has questions about EpiPen maker's profits
Congress has questions about EpiPen maker's profits
October 04, 2016
Top members of a House Oversight Committee investigating EpiPen maker Mylan want more information from the company about the device's profit margins.
Read more at:
http://rss.cnn.com/~r/rss/money_topstories/~3/JyDBhpO9j_w/index.html
Other News
How Trump could lose millions but still seem rich
LinkedIn co-founder slams Trump over tax returns
Nintendo Co. (NTDOY) Upgraded to Buy at Zacks Investment Research
Nutrisystem Inc. (NTRI) Downgraded by Zacks Investment Research
Site Created by finaceandbankingnewsnow.com